コンテンツへスキップ
Merck

Use of ethosuximide and valproate in the treatment of epilepsy.

Neurologic clinics (1986-08-01)
S J Wallace
要旨

Ethosuximide is the drug of first choice in absence seizures. Idiosyncratic side effects are rare. Valproate is effective against absence, generalized tonic-colonic, and partial seizures. It is the drug of choice in photosensitive seizures. Valproate is, on the whole, free from unpleasant side effects, but fatal hepatotoxicity and hyperamnionemia have been reported very rarely.

材料
製品番号
ブランド
製品内容

Sigma-Aldrich
エトスクシミド
Supelco
エトスクシミド, Pharmaceutical Secondary Standard; Certified Reference Material
エトスクシミド, European Pharmacopoeia (EP) Reference Standard